Related Experiment Video
Updated: Apr 5, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Coexisting Mitral Regurgitation Impairs Survival After Transcatheter Aortic Valve Implantation
Hisato Takagi1, Takuya Umemoto1,
1Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.
Background:
It remains unclear whether coexisting and untreated mitral regurgitation (MR) affects survival after transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS). To summarize contemporary evidence, we performed the first metaanalysis of adjusted observational studies reporting post-TAVI mortality in patients with various grades of MR.
Methods:
MEDLINE and EMBASE were searched until February 2015, with a bibliographic review of secondary sources. Eligible studies were observational studies enrolling patients undergoing TAVI for AS and reporting adjusted odds ratios (ORs), hazard ratios (HRs), or both for early (30-day or in-hospital) all-cause mortality, overall all-cause mortality, or both in patients with apparent (significant) versus unapparent (nonsignificant) MR as outcomes.
Results:
Sixteen eligible studies enrolling a total of 13,672 patients undergoing TAVI for AS were identified and included. Pooled analyses of eight studies (representing 9,356 patients) and 14 studies (representing 7,405 patients) respectively demonstrated a statistically significant increase in early (OR 2.17; 95% confidence interval [CI] 1.50 to 3.14; p < 0.0001) and overall all-cause mortality (HR 1.81; 95% CI 1.37 to 2.40; p < 0.0001) in patients with apparent relative to unapparent MR. The exclusion of any single study from the analyses did not substantively alter the overall results of our analyses, and there was no evidence of significant publication bias.
Conclusions:
Coexisting and untreated apparent (usually moderate or severe) MR appears to be associated with an increase in both early and overall mortality after TAVI for AS.
Insights
Untreated mitral regurgitation (MR) significantly increases mortality risk after transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS). This meta-analysis confirms apparent MR is linked to higher early and overall death rates post-TAVI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coexisting mitral regurgitation (MR) impact on survival post-transcatheter aortic valve implantation (TAVI) for aortic stenosis (AS) is unclear.
- Existing evidence on MR and TAVI outcomes is limited.
- A comprehensive analysis of adjusted observational studies is needed.
Purpose of the Study:
- To conduct the first meta-analysis on the association between untreated MR and mortality after TAVI for AS.
- To summarize contemporary evidence from adjusted observational studies.
- To evaluate the impact of different grades of MR on post-TAVI survival.
Main Methods:
- Systematic search of MEDLINE and EMBASE databases up to February 2015.
- Inclusion of observational studies reporting adjusted hazard ratios (HRs) or odds ratios (ORs) for mortality.
- Analysis of early (30-day/in-hospital) and overall all-cause mortality in patients with apparent versus unapparent MR.
Main Results:
- Sixteen studies with 13,672 patients were included.
- Apparent MR was associated with a significant increase in early mortality (OR 2.17; 95% CI 1.50-3.14).
- Apparent MR also significantly increased overall all-cause mortality (HR 1.81; 95% CI 1.37-2.40).
Conclusions:
- Coexisting and untreated apparent MR (moderate to severe) is linked to increased early and overall mortality after TAVI for AS.
- Findings highlight the importance of addressing MR in AS patients undergoing TAVI.
- Further research may be warranted to explore management strategies for MR in this population.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

